STAT

Sam Isaly leaves OrbiMed months after harassment allegations

More than four months after promising to resign, Sam Isaly has stepped down from biotech’s most powerful hedge fund in the wake of allegations of rampant sexual harassment.

More than four months after from biotech’s most powerful hedge fund, Sam Isaly has stepped down from in the wake of allegations of rampant sexual harassment.

You're reading a preview, sign up to read more.

More from STAT

STAT2 min readPolitics
Biden Puts Forth An Elaborate — And Aggressive — Plan To Lower Drug Prices
His new platform includes some of the most aggressive approaches to lowering drug prices any Democratic presidential candidate has proposed to date. 
STAT10 min readPolitics
How Pharma, Under Attack From All Sides, Keeps Winning In Washington
It’s all President Trump and Democrats on Capitol Hill can agree on. So why hasn’t Washington lowered drug prices?
STAT3 min read
Opinion: I Get Asked A Lot About Longevity. It Helps That I’m 104
As scientists pursue longevity and anti-aging research, we wanted to hear from a centenarian on her life experience and thoughts on aging. So we called one.